Propantheline Bromide

Antimuscarinic / Anticholinergic Quaternary ammonium anticholinergic

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog PO 0.25-0.5 mg/kg (up to 1 mg/kg in some cases) q8-12h Duration: As needed; typically 3-7 days for acute conditions
Notes: Titrate to effect; monitor for constipation and urinary retention.
Cat PO 0.25-0.5 mg/kg q12-24h Duration: As needed; typically 3-7 days
Notes: Use cautiously in cats with hyperthyroidism or cardiac disease.
Horse IV 0.014 mg/kg (10 mg/450 kg) q6-8h Duration: As needed for colic or anesthesia
Notes: IV administration should be slow; monitor heart rate.
Cattle IV 0.05-0.1 mg/kg q8-12h Duration: As needed
Notes: Not commonly used; withdrawal times must be observed.
Small Ruminants IV 0.05-0.1 mg/kg q8-12h Duration: As needed
Notes: Use with caution; monitor for bloat.
Rabbit PO 0.5-1 mg/kg q8-12h Duration: As needed
Notes: May cause ileus; use only if necessary.
Bird/Poultry PO 0.01-0.02 mg/kg q8-12h Duration: As needed
Notes: Limited data; use with caution.
Exotic/Other PO 0.01-0.05 mg/kg q8-12h Duration: As needed
Notes: Dose based on extrapolation; monitor closely.

Clinical Indications & Species Uses

General Indications
  • Symptomatic treatment of diarrhea and gastrointestinal hypermotility
  • Adjunct in the management of urinary incontinence
  • Preoperative antisecretory agent
Dog (Canine)
  • Reduction of gastrointestinal motility (e.g., diarrhea, irritable bowel syndrome)
  • Control of urinary incontinence due to detrusor hyperreflexia
  • Reduction of gastric acid secretion (adjunctive therapy for gastritis)
  • Preoperative reduction of salivary and respiratory secretions
Cat (Feline)
  • Reduction of gastrointestinal motility (e.g., diarrhea, inflammatory bowel disease)
  • Control of urinary incontinence due to detrusor hyperreflexia
  • Reduction of gastric acid secretion (adjunctive therapy)
Horse (Equine)
  • Reduction of gastrointestinal motility (e.g., spasmodic colic)
  • Reduction of respiratory secretions during anesthesia
Cattle (Bovine)
  • Reduction of gastrointestinal motility (e.g., diarrhea, bloat)
  • Reduction of respiratory secretions during anesthesia
Small Ruminants (Sheep / Goat)
  • Reduction of gastrointestinal motility (e.g., diarrhea)
  • Reduction of respiratory secretions during anesthesia
Rabbit & Small Mammals
  • Reduction of gastrointestinal motility (e.g., diarrhea, ileus)
  • Reduction of respiratory secretions during anesthesia
Avian & Poultry
  • Reduction of gastrointestinal motility (e.g., diarrhea)
  • Reduction of respiratory secretions during anesthesia
Exotic & Other Species
  • Reduction of gastrointestinal motility in small mammals (e.g., ferrets, guinea pigs)
  • Reduction of respiratory secretions during anesthesia

Pharmacology & Mechanism of Action

Drug Class: Antimuscarinic / Anticholinergic | Pharmacological Group: Quaternary ammonium anticholinergic

Mechanism of Action: Propantheline bromide is a quaternary ammonium compound that competitively antagonizes acetylcholine at muscarinic receptors, thereby inhibiting parasympathetic nerve impulses. It reduces gastrointestinal motility, gastric acid secretion, and salivary and bronchial secretions. Its quaternary structure limits its penetration into the central nervous system, resulting in primarily peripheral antimuscarinic effects.

Pharmacodynamics: Propantheline reduces smooth muscle tone in the gastrointestinal, biliary, and urinary tracts, and decreases gastric acid secretion. It also has antisecretory effects on salivary, bronchial, and sweat glands. The drug's effects are dose-dependent and reversible. It has a rapid onset of action (within 30-60 minutes) and a duration of 4-6 hours in most species.

⚑ Pharmacokinetics Summary

Absorption: Propantheline is poorly and erratically absorbed from the gastrointestinal tract. Oral bioavailability is approximately 10-30% in dogs and cats. Food may reduce absorption.
Distribution: Widely distributed in body tissues but does not cross the blood-brain barrier significantly due to its quaternary ammonium structure. It crosses the placenta minimally and is excreted in small amounts in milk.
Metabolism: Partially metabolized in the liver by hydrolysis and conjugation. The drug undergoes some enterohepatic recirculation.
Excretion: Excreted primarily in urine as unchanged drug and metabolites. A small amount is eliminated in feces via bile.
Half-Life: Dogs: approximately 1-2 hours; Cats: approximately 1-3 hours; Horses: approximately 1-2 hours.
Bioavailability: Oral: 10-30% in dogs and cats; variable in other species.
Protein Binding: Low to moderate; approximately 20-30% bound to plasma proteins.

Available Formulations & Strengths

Oral Tablet 7.5 mg, 15 mg (PO)
Injectable Solution 30 mg/10 mL (3 mg/mL) (IV, IM, SC)

Contraindications & Clinical Warnings

Contraindications:
  • Known hypersensitivity to propantheline or other anticholinergics
  • Glaucoma
  • Obstructive gastrointestinal disease (e.g., ileus, pyloric stenosis)
  • Obstructive uropathy (e.g., urethral obstruction)
  • Myasthenia gravis
  • Tachycardia or cardiac arrhythmias
  • Severe renal or hepatic impairment
Warnings & Clinical Precautions:
  • Use with caution in animals with autonomic neuropathy, hyperthyroidism, congestive heart failure, or prostatic hypertrophy.
  • May cause constipation and urinary retention; monitor bowel and bladder function.
  • In horses, may cause ileus and colic; use only when clearly indicated.
  • In ruminants, may cause bloat; use with caution.
  • Safety in pregnant or lactating animals has not been established; use only when benefits outweigh risks.
  • May cause dry mouth and dysphagia; ensure adequate hydration.
  • Use with caution in animals with fever or high environmental temperatures due to decreased sweating.

Adverse Effects & Reactions

Common:

  • Dry mouth
  • Constipation
  • Urinary retention
  • Mydriasis
  • Tachycardia
  • Decreased gastrointestinal motility

Serious / Severe:

  • Paralytic ileus
  • Severe tachycardia
  • Heat stroke (due to decreased sweating)
  • Respiratory depression (at high doses)

Rare:

  • Hypersensitivity reactions
  • Central nervous system excitation (at very high doses)
  • Paradoxical bradycardia (in neonates)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Other anticholinergics (e.g., atropine, glycopyrrolate) Additive anticholinergic effects; increased risk of toxicity High
Digoxin Increased digoxin absorption due to reduced GI motility; monitor digoxin levels Moderate
Metoclopramide Antagonism of prokinetic effects; reduced GI motility Moderate
Potassium chloride (oral) Increased risk of GI ulceration due to delayed transit Moderate
Phenothiazines (e.g., chlorpromazine) Additive anticholinergic effects Moderate
Antacids Reduced absorption of propantheline; separate administration by 1-2 hours Mild

Overdose & Toxicity Management

Signs of Toxicity:

  • Severe dry mouth
  • Mydriasis
  • Tachycardia
  • Hyperthermia
  • Urinary retention
  • Paralytic ileus
  • CNS excitation (restlessness, confusion)
  • Respiratory depression
  • Seizures (in severe cases)

Emergency Treatment Protocol: Discontinue the drug. Provide supportive care: monitor vital signs, maintain airway, and provide respiratory support if needed. For severe anticholinergic toxicity, administer physostigmine (0.02-0.06 mg/kg IV, slow) as an antidote, but use with caution due to risk of bradycardia and seizures. Symptomatic treatment may include cooling measures for hyperthermia, bladder catheterization for urinary retention, and administration of fluids. In cases of oral overdose, consider gastric lavage if recent ingestion, followed by activated charcoal.

Food Animal Withdrawal Times

πŸ₯© Meat: 7 daysπŸ₯› Milk: 3 days

Withdrawal times are not officially established for propantheline in food animals; these are conservative estimates. Consult regulatory authorities and follow label directions. For cattle and small ruminants, a meat withdrawal of at least 7 days and milk withdrawal of at least 3 days is recommended. For poultry, egg withdrawal is not applicable as propantheline is not approved for use in laying hens.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature (20-25Β°C, excursions permitted to 15-30Β°C).

Light Sensitivity: Light-sensitive β€” protect from direct exposure.

Handling & Special Conditions: Protect from light and moisture. Keep container tightly closed. Do not freeze injectable solutions.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Propantheline bromide is FDA-approved for use in dogs and cats for the treatment of gastrointestinal hypermotility and urinary incontinence. It is not approved for use in food animals, but may be used extra-label under AMDUCA.

Extra-Label (Off-Label) Use: In the US, extra-label use of propantheline in food animals is permitted under AMDUCA only with a valid veterinarian-client-patient relationship and a withdrawal time established by the veterinarian. It is prohibited in lactating dairy cows and in animals producing milk for human consumption if no withdrawal time is established. Use in non-food animals is generally allowed.

Clinical Pearls & Practice Notes

πŸ’‘ Clinical Insights: Propantheline bromide is a useful anticholinergic for managing gastrointestinal hypermotility and urinary incontinence in small animals. It is generally well-tolerated, but its use is limited by side effects such as constipation and urinary retention. In large animals, it is used less frequently due to the risk of ileus and bloat. Dosing should be individualized based on the patient's condition and response. For chronic conditions, consider alternative therapies with fewer side effects. Always monitor for adverse effects, especially in geriatric or debilitated animals. In food animals, adhere to withdrawal times to ensure food safety.

References & Literature

  • πŸ“š Plumb's Veterinary Drug Handbook
  • πŸ“š Papich Veterinary Pharmacology and Therapeutics
  • πŸ“š Compendium of Veterinary Products (CVP)